Life sciences firm Zucara Therapeutics Inc. has secured non-dilutive funding of US$3.9 million for the pre-clinical advancement of its lead drug candidate for diabetes, ZT-01. Zucara’s partner, The Leona M. and Harry B. Helmsley Charitable Trust, will provide the funds in the form of a loan under a program-related investment (PRI). ZT-01 is focused on…
Person: Richard Liggins
Research Money News
Applied Research & Economic Recovery - Third Edition Is Here!
The booklet “Applied Research Supports Economic Recovery” contains stories and messages from colleges and institutes across Canada, including details of leading-edge student projects, state-of-the-art facilities available for use by industry and innovative solutions being co-created by students, faculty and companies.Read More
Conference Proceedings 2019
The proceedings from the 18th Annual RE$EARCH MONEY Conference are now available. Catch up on anything you missed or re-visit the most interesting conference moments with in-depth coverage from Tim Lougheed. Download the proceedings now (free).Read More
Building with CCNB-INNOV… Relationships that go a Long Way! CCNB-INNOV, the applied research and development arm of CCNB has adapted its range of services to better meet the unique needs of the regional shipbuilding industry.
|Applied PeR$pectives is a new monthly blog dedicated to highlighting the innovative work being done in the college and institute community.|
Fast Policy Facts
|December 12, 2018: Requiem for a National Network Program
Trending by Topic
Research Money welcomes its readers to submit articles of either 650 or 1,000 words for its popular Opinion Leader page, on topics of interest to the research and innovation community. We also welcome Letters to the Editor and other feedback. If you would like to submit an article or if your organization has news or events that it would like to appear in Research Money please contact the Managing Editor (email@example.com) for further information.
Research Money on Twitter
- Loading tweets...